{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T14:35:31Z","timestamp":1793284531048,"version":"4.5.0"},"reference-count":11,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","license":[{"start":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Recurrent urinary tract infection (UTI) is commonly defined by episode frequency, but recurrence count alone does not explain why infections recur or which preventive strategy is most appropriate. In everyday practice, patients with postmenopausal hypoestrogenism, post-coital recurrence, low fluid intake, voiding dysfunction, persistent-source relapse, resistant-organism recurrence, or noninfectious urinary symptoms may all receive the same label of recurrent UTI despite having different clinical drivers. This editorial argues that recurrent UTI should be approached as a heterogeneous, phenotype-driven syndrome rather than as a uniform pathway toward repeated antimicrobial treatment or long-term antibiotic suppression. Antibiotics remain essential for acute bacterial infection and selected prophylactic use, but prevention should be preceded by confirmation of recurrent bacterial infection and assessment of the dominant recurrence phenotype. Evidence supporting vaginal estrogen, methenamine hippurate, increased fluid intake in selected patients, and cranberry products illustrates the potential value of targeted non-antibiotic prevention, while negative trial evidence for d-mannose reinforces the need for evidence discipline rather than indiscriminate supplement use. We propose a practical model of recurrent UTI care based on four steps: confirm, phenotype, prevent, and reassess. This approach aligns clinical management with antimicrobial stewardship, improves diagnostic clarity, and encourages prevention strategies matched to individual patient mechanisms rather than recurrence count alone.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/ms9.0000000000005446","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:41:32Z","timestamp":1786048892000},"page":"5546-5549","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Recurrent urinary tract infection is not one disease: moving from antibiotic suppression to phenotype-guided prevention"],"prefix":"10.1097","volume":"88","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8258-2101","authenticated-orcid":false,"given":"Bilal","family":"Ahmad","sequence":"first","affiliation":[{"name":"Core Surgical Training, CST-2, Department of Surgery, York & Scarborough Teaching Hospitals NHS Foundation Trust, York, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-7747-2745","authenticated-orcid":false,"given":"Kaleem","family":"Khan","sequence":"additional","affiliation":[{"name":"Department of Surgery and Urology, Balkh University, Mazar-i-Sharif, Balkh, Afghanistan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,8,5]]},"reference":[{"key":"R1-20261029","article-title":"Recurrent uncomplicated urinary tract infections: definitions and risk factors","volume":"9","author":"Cai","year":"2021","journal-title":"GMS Infect Dis"},{"key":"R2-20261029","doi-asserted-by":"crossref","first-page":"e2444495","DOI":"10.1001\/jamanetworkopen.2024.44495","article-title":"Guidelines for the prevention, diagnosis, and management of urinary tract infections in pediatrics and adults: a WikiGuidelines Group consensus statement","volume":"7","author":"Nelson","year":"2024","journal-title":"JAMA Netw Open"},{"key":"R4-20261029","doi-asserted-by":"crossref","first-page":"626","DOI":"10.3390\/microorganisms13030626","article-title":"Etiology and risk factors of recurrent urinary tract infections in women in a multidisciplinary hospital in Romania","volume":"13","author":"Anton","year":"2025","journal-title":"Microorganisms"},{"key":"R5-20261029","doi-asserted-by":"crossref","DOI":"10.3399\/BJGPO.2025.0239","article-title":"Defining recurrent urinary tract infection and reinfection risk: electronic health record study","volume":"10","author":"Vazquez-montes","year":"2026","journal-title":"BJGP Open"},{"key":"R6-20261029","doi-asserted-by":"crossref","first-page":"e0068229","DOI":"10.1136\/bmj-2021-0068229","article-title":"Alternative to prophylactic antibiotics for the treatment of recurrent urinary tract infections in women: multicentre, open label, randomised, non-inferiority trial","volume":"376","author":"Harding","year":"2022","journal-title":"BMJ"},{"key":"R7-20261029","doi-asserted-by":"crossref","first-page":"1873\u201379","DOI":"10.1016\/j.cmi.2025.07.006","article-title":"Methenamine hippurate as prophylaxis for recurrent urinary tract infections in older women: a triple-blind, randomised, placebo-controlled, phase IV trial (ImpresU)","volume":"31","author":"Heltveit-olsen","year":"2025","journal-title":"Clin Microbiol Infect"},{"key":"R8-20261029","doi-asserted-by":"crossref","first-page":"282\u201389","DOI":"10.1097\/JU.0000000000000296","article-title":"Recurrent uncomplicated urinary tract infections in women: AUA\/CUA\/SUFU guideline","volume":"202","author":"Anger","year":"2019","journal-title":"J Urol"},{"key":"R9-20261029","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.3390\/ph16111615","article-title":"Origin of antibiotics and antibiotic resistance, and their impacts on drug development: a narrative review","volume":"16","author":"Muteeb","year":"2023","journal-title":"Pharmaceuticals (Basel)"},{"key":"R10-20261029","first-page":"CD001321","article-title":"Cranberries for preventing urinary tract infections","volume":"4","author":"Williams","year":"2023","journal-title":"Cochrane Database Syst Rev"},{"key":"R11-20261029","doi-asserted-by":"crossref","first-page":"619\u201328","DOI":"10.1001\/jamainternmed.2024.0264","article-title":"d-Mannose for prevention of recurrent urinary tract infection among women: a randomized clinical trial","volume":"184","author":"Hayward","year":"2024","journal-title":"JAMA Intern Med"},{"key":"R12-20261029","doi-asserted-by":"crossref","first-page":"178\u201393","DOI":"10.1002\/nau.25596","article-title":"Phenotyping men with lower urinary tract symptoms: results from the symptoms of lower urinary tract dysfunction research network","volume":"44","author":"Helmuth","year":"2025","journal-title":"Neurourol Urodyn"}],"container-title":["Annals of Medicine &amp; Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MS9.0000000000005446","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T14:03:11Z","timestamp":1793282591000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MS9.0000000000005446"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,5]]},"references-count":11,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/ms9.0000000000005446","relation":{},"ISSN":["2049-0801","2049-0801"],"issn-type":[{"value":"2049-0801","type":"electronic"},{"value":"2049-0801","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8,5]]},"assertion":[{"value":"2026-07-02","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-07","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}